REQUEST A DEMO
Total
USD $0.00
Search more companies

Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Biological Product (except Diagnostic) Manufacturing
Full name: Edding Genor Group Holdings Limited Profile Updated: February 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) is a company in China, with a head office in Shanghai. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on April 10, 2017. Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) currently employs 24 (2024) people. There was a net sales revenue increase of 122.84% reported in Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司)’s latest financial highlights for Q2C2025. Over the same period, its total assets grew by 3.96%. The enterprise’s net profit margin increased by 704.12% in 2025.

Headquarters
Building 3, 1690 Zhangheng Road, Pudong New District
Shanghai; Shanghai; Postal Code: 201203

Contact Details: Purchase the Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) report to view the information.

Website: http://www.genorbio.com

Basic Information
Total Employees:
Purchase the Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) report to view the information.
Outstanding Shares:
Purchase the Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) report to view the information.
Registered Capital:
Purchase the Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) report to view the information.
Financial Auditors:
Purchase the Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) report to view the information.
Incorporation Date:
April 10, 2017
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
24.26%
Purchase this report to view the information.
8.52%
Purchase this report to view the information.
7.22%
Purchase this report to view the information.
5.6%
Purchase this report to view the information.
2.59%
Subsidiaries
Genor Biopharma (Hk) Limited (Hong Kong SAR, China)
100%
Genor Biopharma (Usa), Inc (United States)
100%
Ab Therapeutics Inc. (Abt) (United States)
80%
Company Performance
Financial values in the chart are available after Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
122.84%
Total Operating Revenue
86.58%
Operating Profit
49.5%
EBITDA
45.03%
Net Profit/Loss for the Period
56.94%
Total Assets
3.96%
Total Equity
3.33%
Operating Profit Margin
695.22%
Net Profit Margin
704.12%
Return on Equity (ROE)
6.93%
Debt / Equity
-279%
Quick Ratio
-804.71%
Cash Ratio
-0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?